Byler Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-09-24
Clinical Trial Update: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Clinical trial update indicates the study comparing Buphenyl to Ravicti for Byler disease is no longer available, effectively ending the tra…